Researchers discovered what may be a new approach for creating neuropsychiatric drugs, using a virtual library of compounds derived from chemistry developed by a Yale laboratory.
The new drug candidates they’ve identified through this process could lead...
As far back as kindergarten, Katherine Rotker had her heart set on a career in medicine. A teacher asked her what she wanted to be when she grew up, and she answered, “OB/GYN.”
“They delivered babies, and that sounded fascinating to me,” Rotker says....
Jodi Sherman, an associate professor of anesthesiology at Yale School of Medicine and of epidemiology in environmental health sciences at Yale School of Public Health, will testify Sept. 15 at a U.S. Congressional hearing on what it will take to prepare...
In a new analysis, investigators at the Yale Center for Outcomes Research and Evaluation (CORE) and Harvard indicate that in Massachusetts, a state with a high vaccination rate, the most recent wave of SARS-CoV-2 infection was not associated with an...
Yale researchers have developed a new class of molecules that target some of the deadliest brain cancers while sparing healthy tissue along the way.
The discovery, which combines innovative synthetic chemistry and cutting-edge mechanistic studies in...
In a June 13 announcement, the U.S. Food and Drug Administration approved the use of the Janus kinase (JAK) inhibitor baricitinib as a treatment for severe alopecia areata, a disfiguring skin disease.
It is the first approved treatment for alopecia areata...
Every patient in a Yale clinical trial of a new treatment for the disfiguring disease sarcoidosis saw improvement to their skin — and more than half showed improvement in affected internal organs.
Sarcoidosis is a disease affecting four out of every 10,...
A new study by investigators at the Yale Center for Outcomes Research and Evaluation (CORE) and Harvard shows the Omicron variant of the COVID-19 virus caused more excess deaths in just eight weeks than the Delta variant caused in its entire 23-week...
Dr. Brett King, associate professor of dermatology at Yale School of Medicine, has been named an American Academy of Dermatology (AAD) “Patient Care Hero” for his pioneering work treating conditions such as severe alopecia.
AAD cited King’s innovative use...
In a new study, Yale researchers take a unique approach to identify the molecular signals that induce a critical trigger for hair follicle formation and regeneration.
The findings could prove crucial for developing new therapies to re-grow hair — and...